Pair Name | Luteolin, Gemcitabine | ||
Phytochemical Name | Luteolin (PubChem CID: 5280445 ) | ||
Anticancer drug Name | Gemcitabine (PubChem CID: 60750 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Luteolin, Gemcitabine | |||
Disease Info | [ICD-11: 2C10.0] | Pancreatic ductal adenocarcinoma | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Up-regulation | Expression | BAX | hsa581 |
Down-regulation | Expression | BCL2 | hsa596 | |
Up-regulation | Expression | CASP3 | hsa836 | |
Down-regulation | Expression | CDH13 | hsa1012 | |
Down-regulation | Expression | GSK3B | hsa2932 | |
Down-regulation | Expression | KRAS | hsa3845 | |
In Vitro Model | BxPC-3 | Pancreatic ductal adenocarcinoma | Homo sapiens (Human) | CVCL_0186 |
In Vivo Model | Male athymic nude mice were inoculated with BxPC-3 cells (1×10⁶ cells/mouse) cells | |||
Result | Luteolin + Gem promoted apoptotic cell death in pancreatic tumor cells in vivo through inhibition of the K-ras/GSK-3β/NF-κB signaling pathway, leading to a reduction in the Bcl-2/Bax ratio, release of cytochrome c, and activation of caspase 3. |
No. | Title | Href |
---|---|---|
1 | Luteolin and Gemcitabine Protect Against Pancreatic Cancer in an Orthotopic Mouse Model. Pancreas. 2015 Jan;44(1):144-51. doi: 10.1097/MPA.0000000000000215. | Click |